|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:DNMT1-ZGLP1 (FusionGDB2 ID:23684) |
Fusion Gene Summary for DNMT1-ZGLP1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: DNMT1-ZGLP1 | Fusion gene ID: 23684 | Hgene | Tgene | Gene symbol | DNMT1 | ZGLP1 | Gene ID | 1786 | 100125288 |
| Gene name | DNA methyltransferase 1 | zinc finger GATA like protein 1 | |
| Synonyms | ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT|m.HsaI | GATAD3|GLP-1|GLP1 | |
| Cytomap | 19p13.2 | 19p13.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | DNA (cytosine-5)-methyltransferase 1CXXC-type zinc finger protein 9DNA (cytosine-5-)-methyltransferase 1DNA MTase HsaIDNA methyltransferase HsaI | GATA-type zinc finger protein 1GATA zinc finger domain containing 3GATA-like protein 1 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | P26358 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000340748, ENST00000540357, ENST00000359526, ENST00000589538, | ENST00000403903, ENST00000403352, | |
| Fusion gene scores | * DoF score | 14 X 12 X 11=1848 | 4 X 9 X 4=144 |
| # samples | 17 | 5 | |
| ** MAII score | log2(17/1848*10)=-3.44235810527836 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/144*10)=-1.52606881166759 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: DNMT1 [Title/Abstract] AND ZGLP1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | DNMT1(10266529)-ZGLP1(10416628), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | DNMT1-ZGLP1 seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF. DNMT1-ZGLP1 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. DNMT1-ZGLP1 seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF. DNMT1-ZGLP1 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. DNMT1-ZGLP1 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. DNMT1-ZGLP1 seems lost the major protein functional domain in Tgene partner, which is a transcription factor due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | DNMT1 | GO:0010216 | maintenance of DNA methylation | 18754681|21745816 |
| Fusion gene breakpoints across DNMT1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across ZGLP1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BRCA | TCGA-AR-A1AI-01A | DNMT1 | chr19 | 10266529 | - | ZGLP1 | chr19 | 10416628 | - |
Top |
Fusion Gene ORF analysis for DNMT1-ZGLP1 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000340748 | ENST00000403903 | DNMT1 | chr19 | 10266529 | - | ZGLP1 | chr19 | 10416628 | - |
| Frame-shift | ENST00000340748 | ENST00000403352 | DNMT1 | chr19 | 10266529 | - | ZGLP1 | chr19 | 10416628 | - |
| Frame-shift | ENST00000540357 | ENST00000403903 | DNMT1 | chr19 | 10266529 | - | ZGLP1 | chr19 | 10416628 | - |
| Frame-shift | ENST00000540357 | ENST00000403352 | DNMT1 | chr19 | 10266529 | - | ZGLP1 | chr19 | 10416628 | - |
| Frame-shift | ENST00000359526 | ENST00000403903 | DNMT1 | chr19 | 10266529 | - | ZGLP1 | chr19 | 10416628 | - |
| Frame-shift | ENST00000359526 | ENST00000403352 | DNMT1 | chr19 | 10266529 | - | ZGLP1 | chr19 | 10416628 | - |
| intron-3CDS | ENST00000589538 | ENST00000403903 | DNMT1 | chr19 | 10266529 | - | ZGLP1 | chr19 | 10416628 | - |
| intron-3CDS | ENST00000589538 | ENST00000403352 | DNMT1 | chr19 | 10266529 | - | ZGLP1 | chr19 | 10416628 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for DNMT1-ZGLP1 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for DNMT1-ZGLP1 |
| Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| DNMT1 | . |
| FUNCTION: Methylates CpG residues. Preferentially methylates hemimethylated DNA. Associates with DNA replication sites in S phase maintaining the methylation pattern in the newly synthesized strand, that is essential for epigenetic inheritance. Associates with chromatin during G2 and M phases to maintain DNA methylation independently of replication. It is responsible for maintaining methylation patterns established in development. DNA methylation is coordinated with methylation of histones. Mediates transcriptional repression by direct binding to HDAC2. In association with DNMT3B and via the recruitment of CTCFL/BORIS, involved in activation of BAG1 gene expression by modulating dimethylation of promoter histone H3 at H3K4 and H3K9. Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells (PubMed:24623306). Also required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) (PubMed:24623306). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing (PubMed:24623306). Promotes tumor growth (PubMed:24623306). {ECO:0000269|PubMed:16357870, ECO:0000269|PubMed:18413740, ECO:0000269|PubMed:18754681, ECO:0000269|PubMed:24623306}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for DNMT1-ZGLP1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for DNMT1-ZGLP1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for DNMT1-ZGLP1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | DNMT1 | P26358 | DB01035 | Procainamide | Other | Small molecule | Approved |
| Hgene | DNMT1 | P26358 | DB01035 | Procainamide | Other | Small molecule | Approved |
| Hgene | DNMT1 | P26358 | DB01035 | Procainamide | Other | Small molecule | Approved |
| Hgene | DNMT1 | P26358 | DB01035 | Procainamide | Other | Small molecule | Approved |
| Hgene | DNMT1 | P26358 | DB00928 | Azacitidine | Inhibitor | Small molecule | Approved|Investigational |
| Hgene | DNMT1 | P26358 | DB00928 | Azacitidine | Inhibitor | Small molecule | Approved|Investigational |
| Hgene | DNMT1 | P26358 | DB00928 | Azacitidine | Inhibitor | Small molecule | Approved|Investigational |
| Hgene | DNMT1 | P26358 | DB00928 | Azacitidine | Inhibitor | Small molecule | Approved|Investigational |
| Hgene | DNMT1 | P26358 | DB01099 | Flucytosine | Other | Small molecule | Approved|Investigational |
| Hgene | DNMT1 | P26358 | DB01099 | Flucytosine | Other | Small molecule | Approved|Investigational |
| Hgene | DNMT1 | P26358 | DB01099 | Flucytosine | Other | Small molecule | Approved|Investigational |
| Hgene | DNMT1 | P26358 | DB01099 | Flucytosine | Other | Small molecule | Approved|Investigational |
| Hgene | DNMT1 | P26358 | DB01262 | Decitabine | Inhibitor | Small molecule | Approved|Investigational |
| Hgene | DNMT1 | P26358 | DB01262 | Decitabine | Inhibitor | Small molecule | Approved|Investigational |
| Hgene | DNMT1 | P26358 | DB01262 | Decitabine | Inhibitor | Small molecule | Approved|Investigational |
| Hgene | DNMT1 | P26358 | DB01262 | Decitabine | Inhibitor | Small molecule | Approved|Investigational |
| Hgene | DNMT1 | P26358 | DB00721 | Procaine | Inhibitor | Small molecule | Approved|Investigational|Vet_approved |
| Hgene | DNMT1 | P26358 | DB00721 | Procaine | Inhibitor | Small molecule | Approved|Investigational|Vet_approved |
| Hgene | DNMT1 | P26358 | DB00721 | Procaine | Inhibitor | Small molecule | Approved|Investigational|Vet_approved |
| Hgene | DNMT1 | P26358 | DB00721 | Procaine | Inhibitor | Small molecule | Approved|Investigational|Vet_approved |
Top |
Related Diseases for DNMT1-ZGLP1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | DNMT1 | C3807295 | CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT | 11 | CLINGEN;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Hgene | DNMT1 | C3279885 | Hereditary Sensory and Autonomic Neuropathy Type Ie | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Hgene | DNMT1 | C0036341 | Schizophrenia | 4 | PSYGENET |
| Hgene | DNMT1 | C0005586 | Bipolar Disorder | 2 | PSYGENET |
| Hgene | DNMT1 | C0006142 | Malignant neoplasm of breast | 2 | CTD_human |
| Hgene | DNMT1 | C0024623 | Malignant neoplasm of stomach | 2 | CTD_human |
| Hgene | DNMT1 | C0038356 | Stomach Neoplasms | 2 | CTD_human |
| Hgene | DNMT1 | C0678222 | Breast Carcinoma | 2 | CTD_human |
| Hgene | DNMT1 | C1257931 | Mammary Neoplasms, Human | 2 | CTD_human |
| Hgene | DNMT1 | C1384666 | hearing impairment | 2 | CTD_human;GENOMICS_ENGLAND |
| Hgene | DNMT1 | C1458155 | Mammary Neoplasms | 2 | CTD_human |
| Hgene | DNMT1 | C1708349 | Hereditary Diffuse Gastric Cancer | 2 | CTD_human |
| Hgene | DNMT1 | C4704874 | Mammary Carcinoma, Human | 2 | CTD_human |
| Hgene | DNMT1 | C0001418 | Adenocarcinoma | 1 | CTD_human |
| Hgene | DNMT1 | C0003469 | Anxiety Disorders | 1 | CTD_human |
| Hgene | DNMT1 | C0003865 | Arthritis, Adjuvant-Induced | 1 | CTD_human |
| Hgene | DNMT1 | C0004096 | Asthma | 1 | CTD_human |
| Hgene | DNMT1 | C0007097 | Carcinoma | 1 | CTD_human |
| Hgene | DNMT1 | C0007102 | Malignant tumor of colon | 1 | CTD_human |
| Hgene | DNMT1 | C0009375 | Colonic Neoplasms | 1 | CTD_human |
| Hgene | DNMT1 | C0020071 | Hereditary Sensory Autonomic Neuropathy, Type 1 | 1 | CTD_human |
| Hgene | DNMT1 | C0020072 | Hereditary Sensory Autonomic Neuropathy, Type 2 | 1 | CTD_human |
| Hgene | DNMT1 | C0020074 | HSAN Type IV | 1 | CTD_human |
| Hgene | DNMT1 | C0020075 | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1 | CTD_human |
| Hgene | DNMT1 | C0025149 | Medulloblastoma | 1 | CTD_human |
| Hgene | DNMT1 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
| Hgene | DNMT1 | C0027889 | Hereditary Sensory and Autonomic Neuropathies | 1 | CTD_human |
| Hgene | DNMT1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| Hgene | DNMT1 | C0086405 | Hereditary Sensory Radicular Neuropathy | 1 | CTD_human |
| Hgene | DNMT1 | C0205641 | Adenocarcinoma, Basal Cell | 1 | CTD_human |
| Hgene | DNMT1 | C0205642 | Adenocarcinoma, Oxyphilic | 1 | CTD_human |
| Hgene | DNMT1 | C0205643 | Carcinoma, Cribriform | 1 | CTD_human |
| Hgene | DNMT1 | C0205644 | Carcinoma, Granular Cell | 1 | CTD_human |
| Hgene | DNMT1 | C0205645 | Adenocarcinoma, Tubular | 1 | CTD_human |
| Hgene | DNMT1 | C0205696 | Anaplastic carcinoma | 1 | CTD_human |
| Hgene | DNMT1 | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human |
| Hgene | DNMT1 | C0205698 | Undifferentiated carcinoma | 1 | CTD_human |
| Hgene | DNMT1 | C0205699 | Carcinomatosis | 1 | CTD_human |
| Hgene | DNMT1 | C0205833 | Medullomyoblastoma | 1 | CTD_human |
| Hgene | DNMT1 | C0278510 | Childhood Medulloblastoma | 1 | CTD_human |
| Hgene | DNMT1 | C0278876 | Adult Medulloblastoma | 1 | CTD_human |
| Hgene | DNMT1 | C0282612 | Prostatic Intraepithelial Neoplasias | 1 | CTD_human |
| Hgene | DNMT1 | C0338630 | Senile Paranoid Dementia | 1 | CTD_human |
| Hgene | DNMT1 | C0376280 | Anxiety States, Neurotic | 1 | CTD_human |
| Hgene | DNMT1 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
| Hgene | DNMT1 | C0497327 | Dementia | 1 | CTD_human |
| Hgene | DNMT1 | C0525045 | Mood Disorders | 1 | PSYGENET |
| Hgene | DNMT1 | C0699739 | Sensory Neuropathy, Hereditary | 1 | CTD_human |
| Hgene | DNMT1 | C0751071 | Familial Dementia | 1 | CTD_human |
| Hgene | DNMT1 | C0751291 | Desmoplastic Medulloblastoma | 1 | CTD_human |
| Hgene | DNMT1 | C0887833 | Carcinoma, Pancreatic Ductal | 1 | CTD_human |
| Hgene | DNMT1 | C0971858 | Arthritis, Collagen-Induced | 1 | CTD_human |
| Hgene | DNMT1 | C0993582 | Arthritis, Experimental | 1 | CTD_human |
| Hgene | DNMT1 | C1275668 | Melanotic medulloblastoma | 1 | CTD_human |
| Hgene | DNMT1 | C1279420 | Anxiety neurosis (finding) | 1 | CTD_human |
| Hgene | DNMT1 | C2931852 | Clear-cell metastatic renal cell carcinoma | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies